Glycosphingolipids Prevent APAP and HMG-CoA Reductase Inhibitors-mediated Liver Damage: A Novel Method for “Safer Drug” Formulation that Prevents Drug-induced Liver Injury.
about
Glycosphingolipids Prevent APAP and HMG-CoA Reductase Inhibitors-mediated Liver Damage: A Novel Method for “Safer Drug” Formulation that Prevents Drug-induced Liver Injury.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Glycosphingolipids Prevent APA ...... nts Drug-induced Liver Injury.
@en
Glycosphingolipids Prevent APA ...... nts Drug-induced Liver Injury.
@nl
type
label
Glycosphingolipids Prevent APA ...... nts Drug-induced Liver Injury.
@en
Glycosphingolipids Prevent APA ...... nts Drug-induced Liver Injury.
@nl
prefLabel
Glycosphingolipids Prevent APA ...... nts Drug-induced Liver Injury.
@en
Glycosphingolipids Prevent APA ...... nts Drug-induced Liver Injury.
@nl
P2093
P2860
P356
P1476
Glycosphingolipids Prevent APA ...... ents Drug-induced Liver Injury
@en
P2093
Ami Ben Ya'acov
Dean Nachman
Dimitri Kanovich
Gadi Lalazar
Lida Zolotarov
Madi El Haj
Meir Mizrahi
Tomer Adar
Yaron Ilan
Yehudit Shabat
P2860
P304
P356
10.14218/JCTH.2017.00071
P577
2018-02-14T00:00:00Z